Cited by 318Epilepsy research and treatmentNeuroscience and Neuropharmacology ResearchPharmacological Effects and Toxicity Studies

The DOI matches its Crossref record; 156 of the 157 references it cites were found in a registry or an index.

Antiepileptic Drugs in Non-Epilepsy Disorders: Relations between Mechanisms of Action and Clinical Efficacy

Johannessen Landmark, Cecilie·2008·CNS Drugs

DOI 10.2165/00023210-200822010-00003

Open this paper in CoChat — free account

Abstract

Antiepileptic drugs (AEDs) are used extensively to treat multiple non-epilepsy disorders, both in neurology and psychiatry. This article provides a review of the clinical efficacy of AEDs in non-epilepsy disorders based on recently published preclinical and clinical studies, and attempts to relate this efficacy to the mechanism of action of AEDs and pathophysiological processes associated with the disorders. Some newer indications for AEDs have been established, while others are under investigation. The disorders where AEDs have been demonstrated to be of clinical importance include neurological disorders, such as essential tremor, neuropathic pain and migraine, and psychiatric disorders, including anxiety, schizophrenia and bipolar disorder. Many of the AEDs have various targets of action in the synapse and have several proposed relevant mechanisms of action in epilepsy and in other disorders. Pathophysiological processes disturb neuronal excitability by modulating ion channels, receptors and intracellular signalling pathways, and these are targets for the pharmacological action of various AEDs. Attention is focused on the glutamatergic and GABAergic synapses. In psychiatric conditions such as schizophrenia and bipolar disorder, AEDs such as valproate, carbamazepine and lamotrigine appear to have clear roles based on their effect on intracellular pathways. On the other hand, some AEDs, e.g. topiramate, have efficacy for nonpsychiatric disorders including migraine, possibly by enhancing GABAergic and reducing glutamatergic neurotransmission. AEDs that seem to enhance GABAergic neurotransmission, e.g. tiagabine, valproate, gabapentin and possibly levetiracetam, may have a role in treating neurological disorders such as essential tremor, or anxiety disorders. AEDs with effects on voltage-gated sodium or calcium channels may be advantageous in treating neuropathic pain, e.g. gabapentin, pregabalin, carbamazepine, oxcarbazepine, lamotrigine and valproate. Co-morbid conditions associated with epilepsy, such as mood disorders and migraine, may often respond to treatment with AEDs. Other possible disorders where AEDs may be of clinical importance include cancer, HIV infection, drug and alcohol abuse, and also in neuroprotection. A future challenge is to evaluate the second-generation AEDs in non-epilepsy disorders and to design clinical trials to study their effects in such disorders in paediatric patients. Differentiation between the main mechanisms of action of the AEDs needs more consideration in drug selection for tailored treatment of the various non-epilepsy disorders.

Integrity signals

Registry

Crossref · 10.2165/00023210-200822010-00003

Cites

156 of 156 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells
Göttlicher, M., Minucci, S., Zhu, P., Krämer, O. H., Schimpf, A., Giavara, S., Sleeman, J. P., Coco, F. L., Nervi, C., Pelicci, P. G., et al. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.6969 · Cited by 1,930
Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen
Phiel, C. J., Zhang, F., Huang, E. Y., Guenther, M. G., Lazar, M. A., & Klein, P. S. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101287200 · Cited by 1,758
The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam
Lynch, B. A., Lambeng, N., Nocka, K., Kensel-Hammes, P., Bajjalieh, S. M., Matagne, A., & Fuks, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308208101 · Cited by 1,610
Algorithm for neuropathic pain treatment: An evidence based proposal
Finnerup, N. B., Otto, M., McQuay, H. J., Jensen, T. S., & Sindrup, S. H. (2005) · Pain · doi:10.1016/j.pain.2005.08.013 · Cited by 1,337
The neurobiology of antiepileptic drugs
Rogawski, M. A., & Löscher, W. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1430 · Cited by 1,243
Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
Akbarian, S. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950160008002 · Cited by 1,002
Glutamate and Schizophrenia: Beyond the Dopamine Hypothesis
Coyle, J. T. (2006) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-006-9062-8 · Cited by 917
An astrocytic basis of epilepsy
Tian, G.-F., Azmi, H., Takano, T., Xu, Q., Peng, W., Lin, J., Oberheim, N., Lou, N., Wang, X., Zielke, H. R., et al. (2005) · Nature Medicine · doi:10.1038/nm1277 · Cited by 806
Oral topiramate for treatment of alcohol dependence: A randomised controlled trial
Johnson, B. A., Ait-Daoud, N., Bowden, C. L., DiClemente, C. C., Roache, J. D., Lawson, K., Javors, M. A., & Ma, J. Z. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13370-3 · Cited by 743
Anticonvulsant drugs for management of pain: a systematic review
McQuay, H., Carroll, D., Jadad, A. R., Wiffen, P. J., & Moore, A. (1995) · BMJ · doi:10.1136/bmj.311.7012.1047 · Cited by 712

Show all 157 references

Research works printed but not linked: 14

Lydiard, 2003, J Clin Psychiatry, 64, 21
Nemeroff, 2003, Psychopharmacol Bull, 37, 133
Kralic, 2005, J Clin Invest, 115, 584, 10.1172/JCI200523625 · DOI
Chetcuti, 2005, Int J Neuropsychopharmacol, 28, 1
Keck, 2005, JClin Psychiatry, 67, 8
Premkumar, 2006, Cochrane Database Syst Rev, &NA;, CD005962
Drake, 2001, Cephalalgia, 21, 373
Krusz, 2001, Cephalalgia, 21, 373
Keck, 1993, J Clin Psychiatry, 54, 305
Manji, 2001, Psychopharmacol Bull, 35, 5
Owens, 2003, Psychopharmacol Bull, 37, 17
Henry, 2003, Psychopharmacol Bull, 37, 5
Myrick, 2003, Prim Psychiatry, 10, 59
De Paulis, 2003, Curr Opin Invest Drug, 4, 863

Sorted by citations

Items 101–200 of 318

Pharmaceutical “Gold” from Neurostabilizing Agents: Topiramate and Successor Molecules
Maryanoff, B. E. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900141j · Cited by 33
Characterization of the Time Course of Carbamazepine Deinduction by an Enzyme Turnover Model
Punyawudho, B., Cloyd, J. C., Leppik, I. E., Ramsay, R. E., Marino, S. E., Pennell, P. B., White, J. R., & Birnbaum, A. K. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948050-00003 · Cited by 33
Carbamazepine Attenuates Astroglial L-Glutamate Release Induced by Pro-Inflammatory Cytokines via Chronically Activation of Adenosine A2A Receptor
Okada, M., Fukuyama, K., Shiroyama, T., & Ueda, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20153727 · Cited by 31
Carbamazepine attenuates inducible nitric oxide synthase expression through Akt inhibition in activated microglial cells
Wang, C.-H., Hsiao, C., Lin, Y.-N., Wu, J.-W., Kuo, Y.-C., Lee, C., & Hsiao, G. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2014.898074 · Cited by 32
Use of Antiepileptic Drugs for Hyperkinetic Movement Disorders
Siniscalchi, A., Gallelli, L., & Sarro, G. D. (2010) · Current Neuropharmacology · doi:10.2174/157015910793358187 · Cited by 32
Antiepileptic drugs with mood stabilizing properties and their relation with psychotropic drug use in institutionalized epilepsy patients with intellectual disability
Leunissen, C. L. F., de la Parra, N. M., Tan, F. I. Y., Rentmeester, T. W., Vader, C. I., Veendrick, M. J. B. M., & Aldenkamp, A. P. (2011) · Research in Developmental Disabilities · doi:10.1016/j.ridd.2011.06.007 · Cited by 31
Safety aspects of antiepileptic drugs—focus on pharmacovigilance
Landmark, C. J., & Johannessen, S. I. (2011) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.2269 · Cited by 30
Phenotypic Assessment and the Discovery of Topiramate
Maryanoff, B. E. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00176 · Cited by 29
Survivorship: Pain Version 1.2014
Denlinger, C. S., Ligibel, J. A., Are, M., Baker, K. S., Demark‐Wahnefried, W., Friedman, D. L., Goldman, M. E., Jones, L. W., King, A. A., Ku, G., et al. (2014) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2014.0054 · Cited by 30
Voltage-gated sodium channels: the search for subtype-selective analgesics
England, S. (2008) · Expert Opinion on Investigational Drugs · doi:10.1517/13543780802514559 · Cited by 30
Erratum to: Changes in utilisation of antiepileptic drugs in epilepsy and non-epilepsy disorders—A pharmacoepidemiological study and clinical implications
Baftiu, A., Landmark, C. J., Rusten, I. R., Feet, S. A., Johannessen, S. I., & Larsson, P. G. (2017) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-017-2252-0 · Cited by 30
Temporal trends and patterns in carbamazepine use, related severe cutaneous adverse reactions, and HLA ‐B*15:02 screening: A nationwide study
Lin, C.-W. G., Huang, W., Chao, P., Chen, W., & Hsiao, F. (2018) · Epilepsia · doi:10.1111/epi.14599 · Cited by 29
Effects of different pharmacologic smoking cessation treatments on body weight changes and success rates in patients with nicotine dependence: A network meta‐analysis
Hsieh, M., Tseng, P., Wu, Y., Tu, Y., Wu, H., Hsu, C., Lei, W., Stubbs, B., Carvalho, A. F., Liang, C., et al. (2019) · Obesity Reviews · doi:10.1111/obr.12835 · Cited by 30
Effect of topiramate augmentation in chronic schizophrenia: a placebo-controlled trial.
Behdani, F., Hebrani, P., Ardanı, A. R., & Rafee, E. (2011) · PubMed · Cited by 29
Novel, Broad-Spectrum Anticonvulsants Containing a Sulfamide Group: Pharmacological Properties of ( S )- N -[(6-Chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide (JNJ-26489112)
McComsey, D. F., Smith‐Swintosky, V. L., Parker, M. H., Brenneman, D. E., Malatyńska, E., White, H. S., Klein, B. D., Wilcox, K. S., Milewski, M. E., Herb, M., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm400894u · Cited by 28
Voltage-Gated Na+ Channels
Mantegazza, M., & Catterall, W. A. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0004 · Cited by 29
Optimization of Therapy in Patients with Epilepsy and Psychiatric Comorbidities: Key Points
Pisani, F., Pisani, L. R., Barbieri, M. A., de León, J., & Spina, E. (2022) · Current Neuropharmacology · doi:10.2174/1570159x20666220526144314 · Cited by 27
A fMRI Evaluation of Lamotrigine for the Treatment of Trigeminal Neuropathic Pain: Pilot Study
Scrivani, S. J., Wallin, D. J., Moulton, E. A., Cole, S. H., Wasan, A. D., Lockerman, L. Z., Bajwa, Z. H., Upadhyay, J., Becerra, L. R., & Borsook, D. (2010) · Pain Medicine · doi:10.1111/j.1526-4637.2010.00859.x · Cited by 27
Pain following the repair of an abdominal hernia
Hansen, M. B., Andersen, K. G., & Crawford, M. E. (2009) · Surgery Today · doi:10.1007/s00595-009-4001-1 · Cited by 27
Therapeutic Drug Monitoring of Newer Antiepileptic Drugs
McMillin, G. A., & Krasowski, M. D. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802025-8.00005-2 · Cited by 27
Modifications of Antiepileptic Drugs for Improved Tolerability and Efficacy
Landmark, C. J., & Johannessen, S. I. (2008) · Perspectives in Medicinal Chemistry · doi:10.1177/1177391x0800200001 · Cited by 28
Selected pharmacokinetic issues of the use of antiepileptic drugs and parenteral nutrition in critically ill patients
Salih, M. R. M., Bahari, M. B., & Abd, A. Y. (2010) · Nutrition Journal · doi:10.1186/1475-2891-9-71 · Cited by 26
Population Pharmacokinetics of Carbamazepine in Elderly Patients
Punyawudho, B., Ramsay, E., Brundage, R. C., Macias, F. M., Collins, J. F., & Birnbaum, A. K. (2012) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0b013e31824d6a4e · Cited by 26
Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis
Beiske, G., Holmøy, T., Beiske, A. G., Johannessen, S. I., & Landmark, C. J. (2015) · Multiple Sclerosis International · doi:10.1155/2015/317859 · Cited by 25
An open pilot study of tiagabine in alcohol dependence: tolerability and clinical effects
Paparrigopoulos, T. J., Tzavellas, E., Karaiskos, D., Malitas, P. N., & Liappas, I. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881109103799 · Cited by 25
The amygdala to periaqueductal gray pathway: Plastic changes induced by audiogenic kindling and reversal by gabapentin
Tupal, S., & Faingold, C. L. (2012) · Brain Research · doi:10.1016/j.brainres.2012.07.044 · Cited by 24
The extent of cytochrome P450 3A induction by antiseizure medications: A systematic review and network meta‐analysis
Cohen, H., Mahajna, G., Ben‐Shushan, T., Matok, I., & Eyal, S. (2023) · Epilepsia · doi:10.1111/epi.17822 · Cited by 24
Lithium-Responsive Seizure-Like Hyperexcitability Is Caused by a Mutation in the Drosophila Voltage-Gated Sodium Channel Gene paralytic
Kaas, G. A., Kasuya, J., Lansdon, P., Ueda, A., Iyengar, A. S. R., Wu, C., & Kitamoto, T. (2016) · eNeuro · doi:10.1523/eneuro.0221-16.2016 · Cited by 27
Protective Effects of Zonisamide Against Rotenone-Induced Neurotoxicity
Condello, S., Currò, M., Ferlazzo, N., Costa, G., Visalli, G., Caccamo, D., Pisani, L. R., Costa, C., Calabresi, P., Ientile, R., et al. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1181-2 · Cited by 23
Clinical Pharmacokinetic Monitoring of Free Valproic Acid Levels: A Systematic Review
Lin, K., Cao, V., Au, C., & Dahri, K. M. (2022) · Clinical Pharmacokinetics · doi:10.1007/s40262-022-01171-w · Cited by 23
Synthesis and pharmacological properties of new GABA uptake inhibitors
Sałat, K., Więckowska, A., Więckowski, K., Höfner, G. C., Kamiński, J., Wanner, K. T., Malawska, B., Filipek, B., & Kulig, K. (2012) · Pharmacological Reports · doi:10.1016/s1734-1140(12)70877-0 · Cited by 23
Simultaneous determination of four antiepileptic drugs in human plasma samples using an ultra‐high‐performance liquid chromatography tandem mass spectrometry method and its application in therapeutic drug monitoring
Dupouey, J., Doudka, N., Belo, S., Blin, O. J., & Guilhaumou, R. (2016) · Biomedical Chromatography · doi:10.1002/bmc.3789 · Cited by 23
Therapeutic Drug Monitoring of Second- and Third-Generation Antiepileptic Drugs
Krasowski, M. D., Long, T. A., Snozek, C. L. H., Dizon, A., Magnani, B., & Melanson, S. E. F. (2021) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2020-0562-cp · Cited by 22
The Face of Chronic Migraine: Epidemiology, Demographics, and Treatment Strategies
Vargas, B. B., & Dodick, D. W. (2009) · Neurologic Clinics · doi:10.1016/j.ncl.2009.01.001 · Cited by 21
Antiepileptic drugs ( AED s) during pregnancy and risk of congenital jaw and oral malformation
Koo, J., & Zavras, A. I. (2012) · Oral Diseases · doi:10.1111/odi.12061 · Cited by 21
Drugs That Disturb Sleep and Wakefulness
Schweitzer, P. K. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-6645-3.00046-3 · Cited by 21
Antiseizure Medications for the Prophylaxis of Migraine during the Anti- CGRP Drugs Era
Rollo, E., Romozzi, M., Vollono, C., Calabresi, P., Geppetti, P., & Iannone, L. F. (2022) · Current Neuropharmacology · doi:10.2174/1570159x21666221228095256 · Cited by 20
Trichotillomania: A Case of Response to Valproic Acid
Adewuya, E. C., Zinser, W., & THOMAS, C. R. (2008) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2008.076 · Cited by 20
Activation of suicidal ideation with adjunctive rufinamide in bipolar disorder
Kaufman, K. R., & Struck, P. J. (2010) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2010.11.014 · Cited by 19
Is intractable epilepsy a tauopathy?
Xi, Z., Wang, X., Shu, X.-F., Chen, G., Xiao, F., Sun, J., & Zhu, X. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.03.003 · Cited by 19
Sensitization, epileptic-like symptoms and local synchronization in patients with paranoid schizophrenia
Bob, P., Paluš, M., Šusta, M., & Gláslová, K. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.10.015 · Cited by 19
Availability of antiepileptic drugs across Europe
Baftiu, A., Landmark, C. J., Nikaj, V., Neslein, I. L., Johannessen, S. I., & Perucca, E. (2015) · Epilepsia · doi:10.1111/epi.13210 · Cited by 19
The α2δ Subunit and Absence Epilepsy: Beyond Calcium Channels?
Celli, R., Santolini, I., Guiducci, M., van Luijtelaar, G., Parisi, P., Striano, P., Gradini, R., Battaglia, G., Ngomba, R. T., & Nicoletti, F. (2017) · Current Neuropharmacology · doi:10.2174/1570159x15666170309105451 · Cited by 19
Pregabalin in the management of partial epilepsy
Arain, A. M. (2009) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s3850 · Cited by 18
Evolution of stereotypies in adolescents and women with Rett syndrome
Vignoli, A., Briola, F. L., & Canevini, M. P. (2009) · Movement Disorders · doi:10.1002/mds.22595 · Cited by 18
Remedial dosing recommendations for delayed or missed doses of valproic acid in patients with epilepsy based on Monte Carlo simulations
Wang, C., Jiao, Z., Ding, J., Yu, E.-Q., & Zhu, G. (2020) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2020.107265 · Cited by 17
Conservative Treatment for Neck Pain: Medications, Physical Therapy, and Exercise
Pangarkar, S. S., & Lee, P. C. (2011) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2011.04.001 · Cited by 17
Psychopharmacological treatments in HIV patients under antiretroviral therapy.
Gallego, L., Barreiro, P., & López-Ibor, J. J. (2012) · PubMed · Cited by 17
Control of Granule Cell Dispersion by Natural Materials Such as Eugenol and Naringin: A Potential Therapeutic Strategy Against Temporal Lobe Epilepsy
Kim, S. R. (2016) · Journal of Medicinal Food · doi:10.1089/jmf.2016.3712 · Cited by 16
Blocking α2δ-1 Subunit Reduces Bladder Hypersensitivity and Inflammation in a Cystitis Mouse Model by Decreasing NF-kB Pathway Activation
Boudieu, L., Mountadem, S., Lashermes, A., Méleine, M., Ulmann, L., Rassendren, F., Aissouni, Y., Sion, B., Carvalho, F. A., & Ardid, D. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00133 · Cited by 18
Pharmacogenomic Characterization in Bipolar Spectrum Disorders
Fortinguerra, S., Sorrenti, V., Giusti, P., Zusso, M., & Buriani, A. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics12010013 · Cited by 18
Anticonvulsant use and bone health in a population-based study of men and women: cross-sectional data from the Geelong Osteoporosis Study
Chandrasekaran, V., Pasco, J. A., Stuart, A. L., Brennan-Olsen, S. L., Berk, M., Hodge, J. M., Samarasinghe, R. M., & Williams, L. J. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04042-w · Cited by 18
Efficacy and Tolerability of Pregabalin Versus Topiramate in the Prophylaxis of Chronic Daily Headache With Analgesic Overuse
Rizzato, B., Leone, G., Misaggi, G., Zivi, I., & Diomedi, M. (2011) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e318210ecc9 · Cited by 17
Topiramate reduces basal anxiety and relieves ethanol withdrawal-induced anxious behaviors in male rats.
Junqueira-Ayres, D. D., Asth, L., Ayres, A. S. F. S. J., Soares, B. L., Soares-Rachetti, V. D. P., & Gavioli, E. C. (2017) · Experimental and Clinical Psychopharmacology · doi:10.1037/pha0000118 · Cited by 17
Molecular Basic of Pharmacotherapy of Cytokine Imbalance as a Component of Intervertebral Disc Degeneration Treatment
Shnayder, N. A., Ashkhotov, A. V., Trefilova, V. V., Nurgaliev, Z. A., Novitsky, M. A., Петрова, М. М., Narodova, E. A., Al-Zamil, M., Chumakova, G. A., Garganeeva, N. P., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24097692 · Cited by 18
Pregnane X receptor and hepatocyte nuclear factor 4α polymorphisms are cooperatively associated with carbamazepine autoinduction
Saruwatari, J., Yoshida, S., Tsuda, Y., Okada, Y., Ogusu, N., Yoshida, K., Oniki, K., Yasui‐Furukori, N., Kaneko, S., Ishitsu, T., et al. (2014) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000030 · Cited by 16
Impact of varying outcomes and definitions of suicidality on the associations of antiepileptic drugs and suicidality: comparisons from UK Clinical Practice Research Datalink (CPRD) and Danish national registries (DNR)
Schuerch, M., Gasse, C., Robinson, N. J., Alvarez, Y., Walls, R., Mors, O. N., Christensen, J., Hesse, U., de Groot, M., Schlienger, R. G., et al. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3928 · Cited by 16
Safety aspects of antiepileptic drugs—a population-based study of adverse effects relative to changes in utilisation
Baftiu, A., Lima, M. H., Svendsen, K., Larsson, P. G., Johannessen, S. I., & Landmark, C. J. (2019) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-019-02678-1 · Cited by 16
Migraine Prophylaxis With Topiramate and Bone Health in Women
Ali, I., Herial, N. A., Orris, M., Horrigan, T. P., & Tietjen, G. E. (2011) · Headache The Journal of Head and Face Pain · doi:10.1111/j.1526-4610.2011.01863.x · Cited by 15
Investigating psychotropic properties of antiepileptic drugs
Mula, M. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/ern.13.57 · Cited by 15
Voluntary alcohol consumption and plasma beta-endorphin levels in alcohol preferring rats chronically treated with levetiracetam: A preliminary study
Zalewska-Kaszubska, J., Bajer, B., Czarnecka, E., Dyr, W., & Górska, D. (2010) · Physiology & Behavior · doi:10.1016/j.physbeh.2010.12.021 · Cited by 15
Can we use psychoactive drugs to treat pruritus?
Reszke, R., & Szepietowski, J. C. (2019) · Experimental Dermatology · doi:10.1111/exd.13959 · Cited by 15
Cortical and hippocampal EEG effects of neurotransmitter agonists in spontaneously hypertensive vs. kainate-treated rats.
Vorobyov, V., Schibaev, N., Kaptsov, V., Kovalev, G., & Sengpiel, F. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.107 · Cited by 17
Repurposing Antiepileptic Drugs for Cancer: A Promising Therapeutic Strategy
Tarawneh, N., Hussein, S. N., & Abdalla, S. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14082673 · Cited by 15
Is Antiepileptic-Induced Suicidality a Data-Based Class Effect or an Exaggeration? A Comment on the Literature
Siamouli, M., Samara, M. T., & Fountoulakis, K. Ν. (2014) · Harvard Review of Psychiatry · doi:10.1097/hrp.0000000000000039 · Cited by 14
Antiepileptic drug use in a nursing home setting: a retrospective study in older adults
Callegari, C. (2016) · Functional Neurology · doi:10.11138/fneur/2016.31.2.087 · Cited by 13
Cross-Reactivity of Ryanodine Receptors with Plasma Membrane Ion Channel Modulators
Neumann, J. T., & Copello, J. A. (2011) · Molecular Pharmacology · doi:10.1124/mol.111.071167 · Cited by 14
Anti-seizure Medications: Challenges and Opportunities
Tandon, N., Radosavljević, M., Vučević, D. B., Radenković, M., Jančić, J., & Samardžić, J. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273275793231030060833 · Cited by 14
Therapeutic monitoring of antiepileptic drugs
Landmark, C. J., & Johannessen, S. I. (2019) · Handbook of analytical separations · doi:10.1016/b978-0-444-64066-6.00010-1 · Cited by 13
Pharmacological characterization of nicotine-induced tremor: Responses to anti-tremor and anti-epileptic agents
Kunisawa, N., Shimizu, S., Kato, M., Iha, H. A., Iwai, C., Hashimura, M., Ogawa, M., Kawaji, S., Kawakita, K., Abé, K., et al. (2018) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2018.05.007 · Cited by 13
Seizure-Sensitivity inDrosophilaIs Ameliorated by Dorsal Vessel Injection of the Antiepileptic Drug Valproate
Howlett, I. C., & Tanouye, M. A. (2013) · Journal of Neurogenetics · doi:10.3109/01677063.2013.817574 · Cited by 13
Subclinical Epileptiform Process in Patients with Unipolar Depression and Its Indirect Psychophysiological Manifestations
Bob, P., Jasová, D., & Raboch, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028041 · Cited by 13
Comparative effects of α2δ-1 ligands in mouse models of colonic hypersensitivity
Méleine, M., Boudieu, L., Gelot, A., Muller, E., Lashermes, A., Matricon, J., Silberberg, C., Théodorou, V., Eschalier, A., Ardid, D., et al. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i31.7111 · Cited by 13
Transcriptomic Analysis in a Drosophila Model Identifies Previously Implicated and Novel Pathways in the Therapeutic Mechanism in Neuropsychiatric Disorders
Singh, P., Mohammad, F., & Sharma, A. (2011) · Frontiers in Neuroscience · doi:10.3389/fnins.2011.00161 · Cited by 13
Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
Gabriel, A. (2010) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s13407 · Cited by 13
Traumatic Stress, Dissociation, and Limbic Irritability in Patients with Unipolar Depression Being Treated with SSRIs
Bob, P., Šusta, M., Gregusova, A., Jasová, D., Raboch, J., & Mishara, A. L. (2010) · Psychological Reports · doi:10.2466/02.15.16.pr0.107.6.685-696 · Cited by 13
Epilepsy and migraine: a diagnostic and therapeutic challenge
Pascarella, A., Marsico, O., Abelardo, D., Cutellè, R., Bulgari, A., Mummolo, C., Mammì, A., Cianci, V., Aguglia, U., Ferlazzo, E., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1649543 · Cited by 12
Prediction of drug–disease associations based on reinforcement symmetric metric learning and graph convolution network
Luo, H., Zhu, C., Wang, J., Zhang, G., Luo, J., & Yan, C. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1337764 · Cited by 12
Differential effects of lacosamide, phenytoin and topiramate on peripheral nerve excitability: An ex vivo electrophysiological study
Zafeiridou, G., Spilioti, M. G., Kagiava, A., Krikonis, K., Kosmidis, E. K., Karlovasitou, A., & Kimiskidis, V. Κ. (2015) · NeuroToxicology · doi:10.1016/j.neuro.2015.10.016 · Cited by 12
Prophylatic treatment of migraine and migraine clinical variants with topiramate: an update
Sergio Carmona, G. (2009) · Therapeutics and Clinical Risk Management · doi:10.2147/tcrm.s3427 · Cited by 12
Epilepsy is more than a simple seizure disorder: Parallels between human and canine cognitive and behavioural comorbidities
Peek, S. I., Meller, S., Twele, F., Packer, R. M. A., & Volk, H. A. (2023) · The Veterinary Journal · doi:10.1016/j.tvjl.2023.106060 · Cited by 14
Protective Effects of Anthocleista djalonensis Extracts against Pentylenetetrazole-Induced Epileptic Seizures and Neuronal Cell Loss: Role of Antioxidant Defense System
Taïwé, G. S., Kouamou, A. L. N., Dabolé, B., Ambassa, A. R. M., Mambou, H. M. A. Y., Bila, R. B., Tchoya, T. B., Menanga, J. R., Dzeufiet, P. D. D., & Bum, E. N. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5523705 · Cited by 11
Scope and Prevalence of the Problem
Adams, H. L., & Matson, J. L. (2015) · Autism and child psychopathology series · doi:10.1007/978-3-319-15437-4_1 · Cited by 11
Modulation of abnormal synaptic transmission in hippocampal CA3 neurons of spontaneously epileptic rats (SERs) by levetiracetam
Hanaya, R., Kiura, Y., Serikawa, T., Kurisu, K., Arita, K., & Sasa, M. (2011) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2011.09.015 · Cited by 11
Graphene oxide–polyaniline nanocomposite as a potential sorbent for dispersive solid-phase extraction and determination of selected pharmaceutical and personal care products in wastewater samples using HPLC with a diode-array detector
Rashvand, M., & Vosough, M. (2016) · Analytical Methods · doi:10.1039/c5ay03182f · Cited by 11
Association of Long-term Antiseizure Medication Use and Incident Type 2 Diabetes Mellitus
Tseng, W.-E. J., Chang, C., Hwang, J., Ko, P., Liu, C., & Lim, S. (2023) · Neurology · doi:10.1212/wnl.0000000000207222 · Cited by 10
Treatment of Transient Peripheral Neuropathy During Chimeric 14.18 Antibody Therapy in Children With Neuroblastoma: A Case Series
Ari, P., Kars, M. S., Meany, H. J., & Pestieau, S. R. (2017) · Journal of Pediatric Hematology/Oncology · doi:10.1097/mph.0000000000000889 · Cited by 10
Calcitonin potentiates the anticonvulsant and antinociceptive effects of valproic acid and pregabalin in pentylenetetrazole-kindled mice
Hamada, N. M., Ashour, R. H., Shalaby, A. A., & EL‐BELTAGI, H. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.11.003 · Cited by 10
An Insight into Gabapentin and Pregabalin in Scottish Prisoners
Deeb, S., Wylie, F. M., Torrance, H. J., & Scott, K. S. (2019) · Journal of Analytical Toxicology · doi:10.1093/jat/bkz105 · Cited by 10
The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids
Tang, H. R., Lu, J., Duan, Y., & Li, D. (2023) · Mediators of Inflammation · doi:10.1155/2023/4893436 · Cited by 10
Probability of Rash Related to Gabapentin Therapy in a Child
Gijsen, V. M. G. J., de Wildt, S. N., & Ito, S. (2009) · Annals of Pharmacotherapy · doi:10.1345/aph.1l354 · Cited by 10
Topiramate-induced depression in cases using topiramate for migraine prophylaxis
Phabphal, K., & Udomratn, P. (2009) · Cephalalgia · doi:10.1111/j.1468-2982.2009.01946.x · Cited by 10
Have antiepileptic drug prescription claims changed following the FDA suicidality warning? An evaluation in a state Medicaid program
Mittal, M., Harrison, D. L., Miller, M. J., Farmer, K. C., Thompson, D. M., & Ng, Y. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.03.017 · Cited by 10
DRUG UTILIZATION EVALUATION OF ANTIEPILEPTICS IN THREE SELECTED MULTIDISCIPLINARY TEACHING HOSPITALS OF PAKISTAN
Mazhar, F., Shamim, S., & Malhi, S. M. (2014) · Cited by 10
Tratamiento del dolor en el paciente con cirrosis hepática
Ojeda, A., & Moreno, L. A. (2013) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2013.05.007 · Cited by 9
Documento de consenso sobre las alteraciones psiquiátricas y psicológicas en adultos y niños con infección por el virus de la inmunodeficiencia humana
(SPNS), G. D. E. D. L. S. D. P. N. S. E. S., (SEP), S. E. D. P., (GESIDA), G. D. E. D. S., & (SEIP), S. E. D. I. P. (2015) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2015.07.018 · Cited by 10
Utilization of Antiepileptic Medicines in Swedish Children and Adolescents with Different Diagnoses
Lind, L. K., Wide, K., Wettermark, B., & von Euler, M. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12981 · Cited by 9
A pharmaco-epidemiological study of migraine and antidepressant medications: Complete one year data from the Norwegian population
Oedegaard, K. J., Riise, T., Dilsaver, S. C., Lund, A., Akiskal, H. S., Fasmer, O. B., & Hundal, Ø. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.09.009 · Cited by 10
Antiepileptic drug treatment of children at a referral centre for epilepsy—Does admission make a difference?
Rytter, E., Landmark, C. J., & Johannessen, S. I. (2009) · Seizure · doi:10.1016/j.seizure.2009.05.011 · Cited by 8
Insights into the role of epigenetic mechanisms in migraine: the future perspective of disease management
Jasrotia, R., Kumar, P., Kundal, B. R., & Langer, S. (2021) · The Nucleus · doi:10.1007/s13237-021-00366-z · Cited by 8

Authors: Johannessen Landmark, C.
Venue: CNS Drugs
Publisher: Springer Science and Business Media LLC
Published: 2008
Volume: 22
Issue: 1
Pages: 27-47
ISSN: 1172-7047 (ISSN-L)
DOI: 10.2165/00023210-200822010-00003
OpenAlex: W2195324906
Cited by: 316
References: 157
Citations by year: 2026: 5 · 2025: 4 · 2024: 11 · 2023: 15 · 2022: 9 · 2021: 7 · 2020: 5 · 2019: 17 · 2018: 10 · 2017: 10 · 2016: 22 · 2015: 15 · 2014: 18 · 2013: 27 · 2012: 28
FWCI: 4.86
Type: journal article
Language: en
Open access: closed
Locations: CNS Drugs (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
Keywords: antiepileptic drugs, off-label drug use, essential tremor, neuropathic pain, migraine, anxiety disorders, schizophrenia, bipolar disorder, GABAergic neurotransmission, glutamatergic neurotransmission, ion channels, valproic acid, carbamazepine, lamotrigine, topiramate, gabapentin, pregabalin, tiagabine, mood disorders, neuroprotection, second-generation antiepileptic drugs, drug selection
MeSH terms: Anticonvulsants, Anxiety, Mental Disorders, Bipolar Disorder, Humans, Migraine Disorders, Nervous System Diseases, Pain, Schizophrenia, Essential Tremor

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Antiepileptic Drugs in Non-Epilepsy Disorders: Relations between Mechanisms of Action and Clinical Efficacy

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks